Spruce Biosciences (NASDAQ:SPRB – Free Report) had its target price upped by JMP Securities from $7.00 to $8.00 in a report released on Wednesday, Marketbeat reports. The brokerage currently has an outperform rating on the stock. A number of other brokerages have also recently commented on SPRB. HC Wainwright restated a buy rating on shares […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 106,500 shares, an increase of 31.5% from the July 15th total of 81,000 shares. Based on an average daily volume of 135,800 shares, the days-to-cover ratio […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totalling 81,000 shares, a decline of 16.3% from the June 30th total of 96,800 shares. Based on an average daily volume of 140,400 shares, the days-to-cover ratio […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 96,800 shares, an increase of 497.5% from the June 15th total of 16,200 shares. Based on an average daily volume of 152,100 shares, the days-to-cover ratio […]
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 96,800 shares, a growth of 497.5% from the June 15th total of 16,200 shares. Based on an average daily volume of 152,100 shares, […]